Clinical Trial Update: Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy [Phase 3]

View source ↗

Summary

Sanofi's Phase 3 trial evaluates docetaxel-based first-line chemotherapy at different doses followed by maintenance therapy in lung cancer; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Lung Neoplasms | Phase 3 | Status: COMPLETED